Skip to main content Skip to main navigation menu Skip to site footer

Association of serum interleukin-10 (IL-10) with the severity of acne vulgaris

  • Tissan Rahmayani ,
  • Imam Budi Putra ,
  • Nelva K Jusuf ,


Background: Acne vulgaris is a common inflammatory disorder in pilosebaceous gland units, which affected more than 90% of teenagers, and half of them settled until adulthood. Inflammation is one of the four critical factors in the pathogenesis of acne vulgaris, and it could be a primary process or secondary to Propionibacterium acnes. The immune system has a various anti-inflammatory mechanism to counter-balance inflammatory mediators. One of the potent cytokines that play a role in regulating the inflammatory state is Interleukin-10 (IL-10). This study conducted to determine the association of serum IL-10 with the severity of acne vulgaris.

Methods: This is a cross-sectional analytic study involving 33 subjects with acne vulgaris and 31 normal-healthy volunteers as a control. Both groups had their serum IL-10 measured. Acne vulgaris severity was assessed with Lehmann criteria. Anova was used to determine the statistical difference of IL-10 among different groups of acne severity. This study has been approved by the Ethical Committee Faculty of Medicine, Universitas Sumatera Utara.

Results: The mean serum IL-10 of normal-healthy and acne vulgaris subjects were 5,79 ± 1,23 pg/ml and 5,25 ± 1,55 pg/ml, respectively. Mann-Whitney test showed a significant difference (p=0,029). The mean IL-10 serum levels according to acne vulgaris severity were 6,63 ± 1,94 pg/ml in the mild category; 4,89 ± 0,95 pg/ml in the moderate category and 4,38 ± 0,61 pg/ml in the severe group. ANOVA showed significant difference with p=0,001.

Conclusion: There was an association between serum levels of IL-10 with the severity of acne vulgaris.


  1. Zaenglein AL, Graber EM, Thiboutot D. Acne vulgaris and acneiformis eruptions. In: Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ, Wolff K, editors. Fitzpatrick’s Dermatology in General Medicine. 8th ed. New York: McGraw Hill Companies; 2012. p.897-917
  2. Dawson AL, Dekkavalle RP. Clinical review: Acne vulgaris. British Medical Journal. 2013; 346:f2634. doi: 10.1136/bmj.f2634
  3. Barratt H, Hamilton F, Car J, Lyons C, Layton A, Majeed A. Outcomes measures in acne vulgaris: systematic review. Br J Dermatol. 2009; 160(3):132-6. doi:10.111/j.1365-2133.1008.08819.x.
  4. Kraft J, Freiman A. Management of acne. Can Med Assoc J. 2011; 183(7):430-5
  5. JK Tan, K Bhate. A global perspective on the epidemiology of acne. Br J Dermatol. 2015; 172(sup1):3-12. doi:10.111/bjd.13462
  6. SZ Ghodsi, H Orawa, CC Zouboulis. Prevalence, severity and severity risk factors of acne in high school pupil: a community-based study. J Inves Dermatol. 2009; 129(9):2136-41. doi:10.1038/jid.2009.47.
  7. Baran R, Chivot M, Shalita AR, Lewis A, Wechsler A. Acne. Baran R, Maibach HI editors. Textbook of Cosmetic Dermatology. 3th Edition. London: Taylor & Francis; 2005; p.423-34
  8. Koreck A, Pivarcsi A, Dobozy A, Kemeny L. The role of innate immunity in the pathogenesis of acne. Dermatology. 2003; 206(1):96-105
  9. Ingham E, Eady EA, Goodwin CE, Cove JH, Cunliffe WJ. Pro-inflammatory levels of interleukin-1 alpha-like bioactivity are present in the majority of open comedones in acne vulgaris. J Invest Dermatol. 1992; 98(6) An Abstract
  10. Tanghetti EA. Literature review: The Role of Inflammation in the Pathology of Acne. J of Clinical Aesthetic Dermatol. 2013; 6(9): 27-35
  11. Mosser DM, Zhang X. Interleukin-10: new perspectives on an old cytokine. Immunol Rev. 2008; 226:205-18
  12. Moore KW, Malefyt RW, Coffman RL, O’Garra A. Interleukin-10 and the Interleukine-10 receptor. Annu Rev Immunol. 2001; 19: 683-765
  13. Kang S, Cho S, Chung JH, Hammerberg C, Fisher GJ, Voorhees JJ. Inflammation and extracellular matrix degradation mediated by activated transcription factors nuclear factor-κB and activator protein-1 in inflammatory acne lesions in vivo. Am J of Pathol. 2005; 166(6):1691-99
  14. Caillon F, O’Connell M, Eady EA, Jenkins G, Cove JH, Layton AM, Mountford AP. Interleukin-10 secretion from CD14+ peripheral blood mononuclear cells is downregulated in patients with acne vulgaris. Br J Dermatol. 2010; 162(2):296-303
  15. Saraiva M, O’Garra A. The Regulation of IL-10 Production by Immune Cells. Nature Review Immunol. 2010; 10:170-81
  16. Demina OM, Kartelishev AV, Karpova EI, Danischuk OI. Role of Cytokines in the Pathogenesis of Acne. International Journal of Biomedicine. 2017; 7(1):37-40
  17. Al-Shobaili HA, Salem TA, Alzolibani AA, Al Robaee A, Settin AA. Tumor Necrosis Factor-α -308 G/A and Interleukin 10 -1082 A/G Gene Polymorphisms in Patients with Acne Vulgaris. Journal of Dermatological Science. 2012; 68:52-5

How to Cite

Rahmayani, T., Putra, I. B., & Jusuf, N. K. (2019). Association of serum interleukin-10 (IL-10) with the severity of acne vulgaris. Bali Medical Journal, 8(3), 753–756.




Search Panel